Algorithmic Biologics logo — Bringing scale efficiencies to molecular discovery and diagn...

Algorithmic Biologics

Bringing scale efficiencies to molecular discovery and diagnostics.

Founded 2021 India India 12 employees Seed Total: $207.00M Biotechnology, Information Technology +1

General Information

Company Name Algorithmic Biologics
Founded Year 2021
Location India India +1
Employees 12
Industries Biotechnology, Information Technology, Clean Energy
Funding Stage Seed
Social

Get notified when Algorithmic Biologics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Algorithmic Biologics

Algorithmic Biologics is a biotechnology and information technology startup based in India, founded in 2021. The company's slogan "Bringing scale efficiencies to molecular discovery and diagnostics" underscores its vision to foster a bountiful and healthy world through enhancing the efficiency of molecular discovery and diagnostics. Algorithmic Biologics stands out for its transdisciplinary team's profound modeling-based expertise in molecular technologies, specifically the chemistry and mechanics aspects. The startup's maiden product, Tapestry, has garnered acclaim and regulatory approval as an algorithmic solution. It facilitates affordable large-scale COVID-19 testing, addressing the pressing need during the pandemic. The recent milestone for Algorithmic Biologics is securing INR207.00M in a Seed Round investment on 3rd February 2024. The investors in this round were Axilor Ventures and Bharat Innovation Fund, both esteemed entities in the investment landscape. This latest injection of funds is poised to fuel the company's momentum, enabling it to forge ahead with its innovative solutions and expand its footprint in the molecular and diagnostic spheres.

Taxonomy: molecular discovery, diagnostics, algorithmic, COVID-19 testing, regulatory approval, transdisciplinary team, chemistry modeling, mechanics modeling, affordable solutions, scale efficiencies, biomedical engineering

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 2
Investor Investor
03 Feb 2024
Non Equity Assistance •••••• 1 •••• •••• 04 Jul 2023
Seed Round •••••• 1
Investor
11 Jan 2022

Algorithmic Biologics Alternatives & Competitors

Algorithmic Biologics vs
Moleculomics
Moleculomics United Kingdom

Working molecular knowledge across genomes

1 employees
Biotechnology
Algorithmic Biologics vs
Versa Quant Inc
Versa Quant Inc United States

Expertise in AI for Equities, Crypto, Commodities & Foreign Exchange Funds.

6 employees
AI, Finance
Algorithmic Biologics vs

Unifying foundation models + physics to reinvent medicine.

FAQ About Algorithmic Biologics

Bringing scale efficiencies to molecular discovery and diagnostics.
Algorithmic Biologics was founded in 2021.
Algorithmic Biologics is headquartered in India.
Algorithmic Biologics operates in the following industries: Biotechnology, Information Technology, Clean Energy.
Algorithmic Biologics has approximately 12 employees.
Algorithmic Biologics has completed 3 funding rounds, raising a total of $207.00M. The latest funding stage is Seed.
Top alternatives and competitors to Algorithmic Biologics include Moleculomics, Versa Quant Inc, Genesis Molecular AI, ChromaCode, Inc., Model Medicines. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Algorithmic Biologics and Moleculomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Algorithmic Biologics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes